Johnson & Johnson
JNJ
#20
Rank
NZ$909.08 B
Marketcap
NZ$377.33
Share price
-0.02%
Change (1 day)
42.48%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

EPS for Johnson & Johnson (JNJ)

EPS in 2025 (TTM): NZ$18.06

According to Johnson & Johnson's latest financial reports the company's current EPS (TTM) is NZ$17.33. In 2024 the company made an earnings per share (EPS) of NZ$11.11 a decrease over its 2023 EPS that were of NZ$23.94.

EPS history for Johnson & Johnson from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$18.0662.56%
2024NZ$11.11-53.6%
2023NZ$23.94111.16%
2022NZ$11.34-13.84%
2021NZ$13.1641.81%
2020NZ$9.28-18.92%
2019NZ$11.4521.2%
2018NZ$9.441125.3%
2017NZ$0.77-92.23%
2016NZ$9.927.37%
2015NZ$9.24-4.16%
2014NZ$9.6418.1%
2013NZ$8.1624.88%
2012NZ$6.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$12.22-29.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.86-83.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.38-22.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$6.16-64.46%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$34.07 96.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$6.15-64.50%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
NZ$10.83-37.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
NZ$12.80-26.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.61-27.26%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.97-65.55%๐Ÿ‡ฌ๐Ÿ‡ง UK